Citigroup’s Phio Pharmaceuticals PHIO Stock Holding History

Citigroup’s Portfolio PHIO Stock Details PHIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$11.9K	Buy	11,605 +10,580	+1,032%	+$12.1K	﹤0.01%	5220
2026 Q1	$1.25K	Buy	+1,025	New	+$1.17K	﹤0.01%	5461
2023 Q4	–	Sell	-102	Closed	-$1.38K	–	5820
2023 Q3	$1.38K	Buy	+102	New	+$2.12K	﹤0.01%	5039
2022 Q2	–	Sell	-9	Closed	-$1K	–	6554
2022 Q1	$1K	Buy	+9	New	+$857	﹤0.01%	6204
2016 Q3	–	Hold	0	–	–	–	7157
2016 Q2	–	Hold	0	–	–	–	7333
2016 Q1	–	Hold	0	–	–	–	7684
2015 Q4	–	Hold	0	–	–	–	7794
2015 Q3	–	Hold	0	–	–	–	7198
2015 Q2	–	Hold	0	–	–	–	7688
2015 Q1	–	Hold	0	–	–	–	7367
2014 Q4	–	Hold	0	–	–	–	7259
2014 Q3	–	Hold	0	–	–	–	7239
2014 Q2	–	Hold	0	–	–	–	7266
2014 Q1	–	Hold	0	–	–	–	6882

Other funds holding PHIO

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

NAMI

Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM

Cetera Investment Advisers Schaumburg, Illinois $110B AUM 26.29% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return

Citigroup's PHIO Position: Q2 2026 in Review

Citigroup increased its Phio Pharmaceuticals (PHIO) stake by 1,032% in Q2 2026, buying an estimated $12.1K and bringing the position to 11,605 shares worth $11.9K. The position accounts for ﹤0.01% of the portfolio, ranked #5220.

Citigroup first reported a position in PHIO in Q1 2022 and has held it in 4 quarters since. 24 funds tracked by Wall St. Rank hold PHIO as of Q2 2026.

Citigroup held 11,605 shares of Phio Pharmaceuticals worth $11.9K as of Q2 2026.
Citigroup bought 10,580 Phio Pharmaceuticals shares in Q2 2026, an estimated $12.1K.
Phio Pharmaceuticals made up ﹤0.01% of Citigroup's portfolio in Q2 2026, its #5220 holding.
Citigroup first reported a position in Phio Pharmaceuticals in Q1 2022 and has held it in 4 quarters since.
24 funds tracked by Wall St. Rank held Phio Pharmaceuticals as of Q2 2026.

Based on Citigroup's 13F filing for Q2 2026, filed 3 Aug 2026.